Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers

Peter C. Fuchs, Arthur L. Barry, Steven D. Brown
Peter C. Fuchs
The Clinical Microbiology Institute, Wilsonville, Oregon 97070
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arthur L. Barry
The Clinical Microbiology Institute, Wilsonville, Oregon 97070
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven D. Brown
The Clinical Microbiology Institute, Wilsonville, Oregon 97070
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.45.6.1915-1918.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table 1.

    Susceptibilities of 5,558 clinical isolates to ertapenem and three comparator drugs

    Microorganism(s) (no. of isolates) and antimicrobial agentbMIC (μg/ml)
    Range50%90%
    Acinetobacterspp.a(86)
     Ertapenem0.06–>164.016
     Imipenem≤0.008–>160.252.0
     Amox-clav0.06–>3216>32
     Ciprofloxacin≤0.008–>161.0>16
    Aeromonas spp.c(21)
     Ertapenem0.03–1.00.060.25
     Imipenem0.25–4.00.52.0
     Amox-clav16–>3232>32
     Ciprofloxacin≤0.008–1.00.0160.12
    Burkholderia cepacia(13)
     Ertapenem4.0–>168.0>16
     Imipenem8.0–>1616>16
     Amox-clav32–32>32>32
     Ciprofloxacin1.0–>164.0>16
    Citrobacter spp.d(216)
     Ertapenem≤0.008–4.0≤0.0080.25
     Imipenem0.06–2.00.51.0
     Amox-clav2.0–>3216>32
     Ciprofloxacin≤0.008–>160.031.0
    Enterobacter spp.e(239)
     Ertapenem≤0.008–>160.030.5
     Imipenem0.12–>161.02.0
     Amox-clav1.0–>32>32>32
     Ciprofloxacin≤0.008–>160.031.0
    Escherichia coli(254)
     Ertapenem≤0.008–0.5≤0.0080.016
     Imipenem0.06–2.00.120.25
     Amox-clav1.0–>328.032
     Ciprofloxacin≤0.008–>160.030.06
    Klebsiella spp.f(359)
     Ertapenem≤0.008–>16≤0.0080.03
     Imipenem0.06–>160.250.5
     Amox-clav1.0–>324.016
     Ciprofloxacin≤0.008–>160.061.0
    Pasteurella multocida(22)
     Ertapenem≤0.008–0.030.0160.03
     Imipenem0.03–0.50.250.5
     Amox-clav0.06–0.50.250.5
     Ciprofloxacin≤0.008–0.06≤0.0080.016
    Proteeaeg(284)
     Ertapenem≤0.008–4.00.0160.03
     Imipenem0.016–164.04.0
     Amox-clav0.5–>3216>32
     Ciprofloxacin≤0.008–>160.06>16
    Pseudomonas aeruginosa(161)
     Ertapenem0.12–>168.0>16
     Imipenem0.25–>162.08.0
     Amox-clav32–>32>32>32
     Ciprofloxacin0.03–>160.5>16
    Pseudomonas spp.h(29)
     Ertapenem≤0.008–>168.0>16
     Imipenem0.12–>161.0>16
     Amox-clav1.0–>32>32>32
     Ciprofloxacin≤0.008–>160.251.0
    Salmonellaspp.i(112)
     Ertapenem≤0.008–0.06≤0.008≤0.008
     Imipenem0.12–1.00.250.5
     Amox-clav1.0–>321.016
     Ciprofloxacin≤0.008–0.120.0160.03
    Serratia marcescens(110)
     Ertapenem≤0.008–>160.030.12
     Imipenem0.12–>161.02.0
     Amox-clav4.0–>32>32>32
     Ciprofloxacin≤0.008–>160.254.0
    Shigella spp.j(37)
     Ertapenem≤0.008≤0.008≤0.008
     Imipenem0.06–0.50.250.25
     Amox-clav4.0–321632
     Ciprofloxacin≤0.008–0.25≤0.0080.06
    Stenotrophomonas maltophilia(54)
     Ertapenem1.0–>16>16>16
     Imipenem8.0–>16>16>16
     Amox-clav4.0–>32>32>32
     Ciprofloxacin1.0–>168.0>16
    Miscellaneous gram-negative bacteriak(22)
     Ertapenem≤0.008–>160.034.0
     Imipenem0.06–>161.04.0
     Amox-clav0.12–>328.032
     Ciprofloxacin≤0.008–>160.54.0
    Haemophilus spp.l(332)
     Ertapenem≤0.008–0.50.030.06
     Imipenem≤0.008–2.00.51.0
     Ampicillin0.12–>4.00.5>4.0
     Ciprofloxacin≤0.008–160.0160.03
    Moraxella catarrhalis(181)
     Ertapenem≤0.008–0.25≤0.0080.016
     Imipenem≤0.008–1.00.120.25
     Ampicillin≤0.03–1.00.250.5
     Ciprofloxacin≤0.008–0.50.0160.03
    Neisseria meningitidis(27)
     Ertapenem≤0.008–0.03≤0.0080.016
     Imipenem0.03–1.00.250.5
     Ampicillin0.12–0.50.120.25
     Ciprofloxacin≤0.008≤0.008≤0.008
    Corynebacterium spp.m(29)
     Ertapenem≤0.008–>160.5>16
     Imipenem≤0.008–>161.0>16
     Amox-clav≤0.03–>320.5>32
     Ciprofloxacin0.5–>16>16>16
    Enterococcus faecalisn(387)
     Ertapenem0.06–>168.0>16
     Imipenem0.03–>162.016
     Amox-clav0.06–>320.51.0
     Ciprofloxacin0.25–>161.0>16
    Enterococcus faeciumo(140)
     Ertapenem0.12–>16>16>16
     Imipenem0.25–>16>16>16
     Amox-clav0.06–>32>32>32
     Ciprofloxacin0.25–>16>16>16
    Enterococcus spp.p(other) (23)
     Ertapenem0.5–>168.0>16
     Imipenem0.03–>164.0>16
     Amox-clav0.12–>321.032
     Ciprofloxacin0.06–>162.0>16
    Staphylococcus aureus
     Oxacillin susceptible (375)
      Ertapenem0.03–>160.120.25
      Imipenem0.016–>160.0160.03
      Amox-clav0.06–8.01.01.0
      Ciprofloxacin0.03–>160.250.5
     Oxacillin resistant (172)
      Ertapenem0.12–>16>16>16
      Imipenem0.03–>1616>16
      Amox-clav0.12–>32>32>32
      Ciprofloxacin0.12–>16>16>16
    Staphylococcus spp., coagulase negative Oxacillin susceptible (182)
     Ertapenem0.03–4.00.120.5
     Imipenem≤0.008–1.00.0160.06
     Amox-clav≤0.03–320.254.0
     Ciprofloxacin0.03–2.00.250.5
    Oxacillin resistant (346)
     Ertapenem0.06–>168.0>16
     Imipenem≤0.008–>161.0>16
     Amox-clav0.12–>3232>32
     Ciprofloxacin0.06–>168.0>16
    Streptococcus agalactiae(206)
     Ertapenem0.016–0.250.060.06
     Imipenem≤0.008–0.060.0160.03
     Amox-clav≤0.03–0.120.060.12
     Ciprofloxacin0.5–4.01.01.0
    Streptococcus pneumoniae
     Penicillin susceptible (373)
      Ertapenem≤0.008–0.060.0160.03
      Imipenem≤0.008–0.03≤0.0080.016
      Amox-clav0.06–0.250.060.06
      Ciprofloxacin0.5–161.02.0
     Penicillin intermediate (93)
      Ertapenem≤0.008–1.00.250.5
      Imipenem≤0.008–0.50.120.25
      Amox-clav≤0.03–2.00.51.0
      Ciprofloxacin0.5–161.02.0
     Penicillin resistant (110)
      Ertapenem0.12–4.01.02.0
      Imipenem0.12–2.00.251.0
      Amox-clav0.12–8.01.08.0
      Ciprofloxacin0.5–8.01.02.0
    Streptococcus pyogenes(238)
     Ertapenem≤0.008–0.25≤0.0080.016
     Imipenem≤0.008–0.06≤0.008≤0.008
     Amox-clav≤0.03–0.12≤0.03≤0.03
     Ciprofloxacin0.12–2.00.51.0
    Streptococcus spp.q(other) (77)
     Ertapenem≤0.008–4.00.120.5
     Imipenem≤0.008–2.00.0160.12
     Amox-clav≤0.03–8.0≤0.030.25
     Ciprofloxacin0.016–160.58.0
    Miscellaneous gram-positive bacteriar(38)
     Ertapenem≤0.008–>160.252.0
     Imipenem≤0.008–4.00.030.12
     Amox-clav0.03–>320.120.5
     Ciprofloxacin0.03–>161.04.0
    Bacteroides fragilis(56)
     Ertapenem0.016–4.00.251.0
     Imipenem≤0.008–2.00.120.5
    Bacteroides spp.s(64)
     Ertapenem0.03–8.00.52.0
     Imipenem0.03–4.00.251.0
    Clostridium perfringens(21)
     Ertapenem≤0.008–0.120.060.06
     Imipenem0.03–0.50.060.12
    Proprionibacterium acnes(21)
     Ertapenem0.03–4.00.060.25
     Imipenem≤0.008–1.0≤0.0080.03
    Miscellaneous anaerobest(48)
     Ertapenem≤0.008–4.00.120.5
     Imipenem≤0.008–2.00.060.25
    • ↵a Species (no. of isolates): A. anitratus (12), A. baumannii(59), A. haemolyticus (8), andA. lwoffii (7).

    • ↵b Amox-clav, amoxicillin-clavulanate.

    • ↵c Species (no. of isolates) A. caviae (3), A. hydrophila(11), and Aeromonas spp. NOS (7).

    • ↵d Species (no. of isolates): C. amalonaticus (8), C. brackii(1), C. diversus (18), C. farmeri (3), C. freundii(119), C. koseri (66), andCitrobacter spp. NOS (1).

    • ↵e Species (no. of isolates): E. aerogenes (111), E. agglomerans(9), E. asburiae (1), E. cancerogenus (1), E. cloacae(112), E. intermedius (2),E. sakasaki (1), and Enterobacterspp. NOS (2).

    • ↵f Species (no. of isolates): K. ornitholytica (1), K. oxytoca(103), and K. pneumoniae (255).

    • ↵g Species (no. of isolates): M. morganii (94), P. mirabilis(113), P. vulgaris (25), P. rettgeri (18), and P. stuartii(34).

    • ↵h Species (no. of isolates): P. fluorescens/putida group (22), P. paucimobilis (1), P. stutzeri(2), P. vesiculare (1), andPseudomonas spp. NOS (3).

    • ↵i Species (no. of isolates): S. enterica serovar Tyhi (3) and non-serovar Typhi salmonellae (109).

    • ↵j Species (no. of isolates): S. bovdii (1), S. flexneri (7),S. sonnei (27), and Shigella spp. NOS (2).

    • ↵k Species (no. of isolates): Alcaligenes faecalis (5), Bordetella bronchiseptica(1), Brevundimonas vesicularis(1), Commamonas spp. (1),Flavobacterium breve (1), F. mengosepticum (1), Hafnia alvei(2), Pasteurella spp. NOS (2),Serratia liquefaciens (1), S. rubidaea (1), Shawanella putrefaciens(1), and Yersinia enterocolitica(5).

    • ↵l Species (no. of isolates): H. aegypticus (1), H. aphrophilus(3), H. haemolyticus (4), H. influenzae (233; 86 β-lactamase-positive), H. parahaemolyticus (1), and H. parainfluenzae (30).

    • ↵m Species (no. of isolates): C. afermentans (1), C. amycolatum(1), C. jeikeium (7; resistant to all drugs), C. pseudodiphtheriticum (1),C. striatum (3), C. ureolyticum(3; resistant to all drugs), andCorynebacterium spp. NOS (13).

    • ↵n Includes 10 vancomycin-resistant strains.

    • ↵o Includes 90 vancomycin-resistant strains.

    • ↵p Species (no. of isolates): E. avium (9), E. casseliflavus(3), E. durans (1), E. gallinarum (8), E. raffinosus(1), and Enterococcus spp. NOS (1).

    • ↵q Species (no. of isolates): group C (5), group F (6), group G (21),S. bovis (6), S. milleri(13), S. mitis (2), S. mutans (2), S. salivarius(3), S. sanguis (4), and S. viridans NOS (15).

    • ↵r Species (no. of isolates):Aerococcus spp. NOS (2), A. urinae(4), Bacillus spp. NOS (8),Lactobacillus spp. NOS (10),Micrococcus spp. NOS (13), and L. monocytogenes (1).

    • ↵s Species (no. of isolates): B. fragilis group, NOS (9), B. ovatus(9), B. thetaiotaomicron (19),B. uniformis (11), B. vulgatus(5), and Bacteroides spp. NOS (11).

    • ↵t Species (no. of isolates):Actinomyces spp. (9),Bifidobacterium spp. (2),Clostridium spp. NOS (9), Eubacterium lentum (2), Fusobacterium spp. (6), Peptostreptococcus spp. (10),Prevotella spp. (6),Propionibacterium spp. NOS (3), andVeillonella parvula (1).

PreviousNext
Back to top
Download PDF
Citation Tools
In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers
Peter C. Fuchs, Arthur L. Barry, Steven D. Brown
Antimicrobial Agents and Chemotherapy Jun 2001, 45 (6) 1915-1918; DOI: 10.1128/AAC.45.6.1915-1918.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers
Peter C. Fuchs, Arthur L. Barry, Steven D. Brown
Antimicrobial Agents and Chemotherapy Jun 2001, 45 (6) 1915-1918; DOI: 10.1128/AAC.45.6.1915-1918.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
carbapenems
Enterobacteriaceae
microbial sensitivity tests

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596